Kazuko Shibuya

6.4k total citations · 2 hit papers
90 papers, 5.0k citations indexed

About

Kazuko Shibuya is a scholar working on Immunology, Immunology and Allergy and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kazuko Shibuya has authored 90 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Immunology, 12 papers in Immunology and Allergy and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kazuko Shibuya's work include Immune Cell Function and Interaction (63 papers), T-cell and B-cell Immunology (48 papers) and Immunotherapy and Immune Responses (21 papers). Kazuko Shibuya is often cited by papers focused on Immune Cell Function and Interaction (63 papers), T-cell and B-cell Immunology (48 papers) and Immunotherapy and Immune Responses (21 papers). Kazuko Shibuya collaborates with scholars based in Japan, United States and United Kingdom. Kazuko Shibuya's co-authors include Akira Shibuya, Anne O’Garra, Kenneth M. Murphy, Nancy Hosken, Satoko Tahara‐Hanaoka, Shin‐ichiro Honda, Andrew W. Heath, Erin Murphy, Douglas S. Robinson and Francesca Zonin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Kazuko Shibuya

88 papers receiving 4.9k citations

Hit Papers

The effect of antigen dos... 1995 2026 2005 2015 1995 1997 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuko Shibuya Japan 34 3.8k 911 805 438 402 90 5.0k
Simon Fillatreau Germany 38 5.0k 1.3× 836 0.9× 735 0.9× 341 0.8× 503 1.3× 80 6.7k
Patrizia Scapini Italy 33 3.5k 0.9× 1.1k 1.2× 1.1k 1.3× 226 0.5× 396 1.0× 50 5.0k
Federica Calzetti Italy 33 2.9k 0.8× 962 1.1× 895 1.1× 297 0.7× 405 1.0× 60 4.3k
Smina Aït‐Yahia France 21 4.0k 1.0× 847 0.9× 1.3k 1.6× 320 0.7× 387 1.0× 22 5.0k
Jean‐François Gauchat Canada 39 3.4k 0.9× 1.1k 1.2× 833 1.0× 834 1.9× 379 0.9× 95 5.4k
Thierry Defrance France 42 4.6k 1.2× 1.3k 1.4× 962 1.2× 407 0.9× 585 1.5× 85 6.7k
Motoko Y. Kimura Japan 32 4.7k 1.2× 1.2k 1.3× 1.1k 1.3× 598 1.4× 311 0.8× 71 6.0k
Daniel Hawiger United States 20 5.8k 1.5× 1.1k 1.2× 933 1.2× 234 0.5× 292 0.7× 36 6.5k
Jean‐Jacques Pin France 19 3.2k 0.8× 694 0.8× 873 1.1× 339 0.8× 379 0.9× 37 4.2k
Michelle A. Linterman United Kingdom 39 5.7k 1.5× 1.1k 1.2× 898 1.1× 317 0.7× 532 1.3× 76 7.2k

Countries citing papers authored by Kazuko Shibuya

Since Specialization
Citations

This map shows the geographic impact of Kazuko Shibuya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuko Shibuya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuko Shibuya more than expected).

Fields of papers citing papers by Kazuko Shibuya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuko Shibuya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuko Shibuya. The network helps show where Kazuko Shibuya may publish in the future.

Co-authorship network of co-authors of Kazuko Shibuya

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuko Shibuya. A scholar is included among the top collaborators of Kazuko Shibuya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuko Shibuya. Kazuko Shibuya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iguchi‐Manaka, Akiko, et al.. (2025). The Development of Monoclonal Antibodies Specific to the Soluble Form of CD155 in the Human Peripheral Blood. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 44(5). 79–83.
2.
Nakahashi-Oda, Chigusa, et al.. (2023). Development of Monoclonal Antibodies Specific to Either CD300A R111 or CD300A Q111 or Both. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 42(5). 182–185. 1 indexed citations
3.
Yamada, Toshiki, Megumi Tatematsu, Shunsuke Takasuga, et al.. (2023). TIGIT mediates activation-induced cell death of ILC2s during chronic airway allergy. The Journal of Experimental Medicine. 220(7). 10 indexed citations
4.
Iguchi‐Manaka, Akiko, et al.. (2022). CD155 mutation (Ala67Thr) increases the binding affinity for and the signaling via an inhibitory immunoreceptor TIGIT. Cancer Science. 113(11). 4001–4004. 8 indexed citations
5.
Matsuda, Kenshiro, et al.. (2022). G307S DNAM-1 Mutation Exacerbates Autoimmune Encephalomyelitis via Enhancing CD4+ T Cell Activation. The Journal of Immunology. 209(12). 2304–2312. 4 indexed citations
6.
Satoh, K., Kazumasa Kanemaru, Masafumi Muratani, et al.. (2021). DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions. Proceedings of the National Academy of Sciences. 118(21). 34 indexed citations
7.
Oh‐oka, Kyoko, et al.. (2021). Suppression of Th1 and Th17 Proinflammatory Cytokines and Upregulation of FOXP3 Expression by a Humanized Anti-DNAM-1 Monoclonal Antibody. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(2). 52–59. 4 indexed citations
8.
Hirochika, Rei, et al.. (2018). TX99 Is a Neutralizing Monoclonal Antibody Against Mouse TIGIT. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 37(2). 105–109. 2 indexed citations
9.
Nakamura, Yoshiyuki, Takashi Matsuzaka, Satoko Tahara‐Hanaoka, et al.. (2018). Elovl6 regulates mechanical damage-induced keratinocyte death and skin inflammation. Cell Death and Disease. 9(12). 1181–1181. 27 indexed citations
10.
Okumura, Genki, et al.. (2017). Development and Characterization of Novel Monoclonal Antibodies Against Human DNAM-1. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 36(3). 135–139. 5 indexed citations
11.
Yamashita, Yumi, et al.. (2013). Establishment and Characterization of a Novel Anti-DNAM-1 Monoclonal Antibody. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 32(1). 60–64. 3 indexed citations
12.
Honda, Shin‐ichiro, Naoki Kurita, Akitomo Miyamoto, et al.. (2009). Enhanced humoral immune responses against T-independent antigens in Fcα/μR-deficient mice. Proceedings of the National Academy of Sciences. 106(27). 11230–11235. 53 indexed citations
13.
Iguchi‐Manaka, Akiko, Hirayasu Kai, Yumi Yamashita, et al.. (2008). Accelerated tumor growth in mice deficient in DNAM-1 receptor. The Journal of Experimental Medicine. 205(13). 2959–2964. 221 indexed citations
14.
Yamada, Akiko, Keigyou Yoh, Takako Nakano, et al.. (2007). Th1 and Type 1 Cytotoxic T Cells Dominate Responses in T-bet Overexpression Transgenic Mice That Develop Contact Dermatitis. The Journal of Immunology. 178(1). 605–612. 39 indexed citations
15.
Tahara‐Hanaoka, Satoko, Naoya Totsuka, Yasushi Okoshi, et al.. (2007). Dual Assemblies of an Activating Immune Receptor, MAIR-II, with ITAM-Bearing Adapters DAP12 and FcRγ Chain on Peritoneal Macrophages. The Journal of Immunology. 178(2). 765–770. 27 indexed citations
16.
Noguchi, Emiko, Yukako Yokouchi, Jiang Zhang, et al.. (2005). Positional Identification of an Asthma Susceptibility Gene on Human Chromosome 5q33. American Journal of Respiratory and Critical Care Medicine. 172(2). 183–188. 55 indexed citations
17.
Kimura, Tōru, Yukio Ishii, Yuko Morishima, et al.. (2004). Treatment with α-Galactosylceramide Attenuates the Development of Bleomycin-Induced Pulmonary Fibrosis. The Journal of Immunology. 172(9). 5782–5789. 39 indexed citations
18.
Murata, Hideyuki, Ryutaro Matsumura, Akio Kôyama, et al.. (2002). T cell receptor repertoire of T cells in the kidneys of patients with lupus nephritis. Arthritis & Rheumatism. 46(8). 2141–2147. 51 indexed citations
19.
Murphy, Erin, Kazuko Shibuya, Nancy Hosken, et al.. (1996). Reversibility of T helper 1 and 2 populations is lost after long-term stimulation.. The Journal of Experimental Medicine. 183(3). 901–913. 371 indexed citations
20.
Hosken, Nancy, Kazuko Shibuya, Andrew W. Heath, Kenneth M. Murphy, & Anne O’Garra. (1995). The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model.. The Journal of Experimental Medicine. 182(5). 1579–1584. 639 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026